Clinical trial

Evaluation of the Efficacy of Combination Treatment With Anakinra and…

NCT00037700 · Amgen, Industry · Completed

Key facts

NCT number NCT00037700
Title Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis
Lead sponsor Amgen, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Rheumatoid Arthritis
Intervention type Drug
Interventions anakinra, pegsunercept
Start date May 1, 2001
Completion Dec 1, 2002
First posted May 21, 2002
Last update posted Nov 26, 2009

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies